SELB - Selecta Biosciences GAAP EPS of -$0.14 misses by $0.05 revenue of $5.9M misses by $6.24M
2023-05-04 07:50:06 ET
- Selecta Biosciences press release ( NASDAQ: SELB ): Q1 GAAP EPS of -$0.14 misses by $0.05 .
- Revenue of $5.9M (-82.6% Y/Y) misses by $6.24M .
- $127.5 million in cash, cash equivalents, restricted cash, and marketable securities as of March 31, 2023.
For further details see:
Selecta Biosciences GAAP EPS of -$0.14 misses by $0.05, revenue of $5.9M misses by $6.24M